Automated Regulatory Intelligence & Surveillance
Continuous 24/7 monitoring of FDA, EMA, Health Canada, MHRA, and CDSCO updates. Deliver clear, verified document summaries filtered precisely to your therapeutic areas.
Adaptive Clinical Trial Designs for Drugs & Biologics
Executive Summary:Updated FDA guidance establishes revised thresholds for Bayesian adaptive trial interim analyses, requiring documented data monitoring committee protocols prior to Phase II initiation.
Expanded Approval Granted for Targeted Immunotherapy
Executive Summary:EMA CHMP recommended approval for second-line treatment of relapsed mantle cell lymphoma following Phase III progression-free survival metrics.